Expert Review of Hematology

Article	Citations
Evidence-based indications of platelet-rich plasma therapy	63
Managing hypogammaglobulinemia in patients treated with CAR-T-cell therapy: key points for clinicians	37
Clinical challenges and promising therapies for chemotherapy-induced thrombocytopenia	37
The biology and management of dyskeratosis congenita and related disorders of telomeres	36
Pacritinib for the treatment of patients with myelofibrosis and thrombocytopenia	33
A review of FDA-approved acute myeloid leukemia therapies beyond ‘7 + 3’	33
COVID-19 associated with immune thrombocytopenia: a systematic review and meta-analysis	28
Immune thrombocytopenia	25
The spectrum of beta-thalassemia mutations in the 22 Arab countries: a systematic review	23
Complement activation and coagulopathy - an ominous duo in COVID19	22
Real-world effectiveness of voxelotor for treating sickle cell disease in the US: a large claims data analysis	22
Avapritinib for Systemic Mastocytosis	20
Platelets: the point of interconnection among cancer, inflammation and cardiovascular diseases	20
The expression of CD30 and its clinico-pathologic significance in peripheral T-cell lymphomas	20
Safety of FLT3 inhibitors in patients with acute myeloid leukemia	19
Heparin-induced thrombocytopenia: pathophysiology, diagnosis and treatment	18
Key questions in the new hemophilia era: update on concomitant use of FVIII and emicizumab in hemophilia A patients with inhibitors	18
Cardiotoxicity of BTK inhibitors: ibrutinib and beyond	17
Diagnostic and therapeutic challenges in hairy cell leukemia-variant: where are we in 2021?	16
Improving outcomes and quality of life for patients with transfusion-dependent β-thalassemia: recommendations for best clinical practice and the use of novel treatment strategies	16
Idecabtagene vicleucel versus ciltacabtagene autoleucel: a Sophie’s choice for patients with relapsed refractory multiple myeloma	15
Hematological manifestations and complications of Gaucher disease	15
Hemostatic defects in massive transfusion: an update and treatment recommendations	15
Voxelotor for the treatment of sickle cell disease	15
Novel BCR-ABL1 tyrosine kinase inhibitors in the treatment of chronic myeloid leukemia	15

MRI detection of brain abnormality in sickle cell disease	14
Apoptosis targeted therapies in acute myeloid leukemia: an update	14
Biomarkers for acute and chronic graft versus host disease: state of the art	14
Chromosomal 1q21 abnormalities in multiple myeloma: a review of translational, clinical research, and therapeutic strategies	14
Transplant-associated thrombotic microangiopathy: elucidating prevention strategies and identifying high-risk patients	13
Phase II single-arm study of brentuximab vedotin in Chinese patients with relapsed/refractory classical Hodgkin lymphoma or systemic anaplastic large cell lymphoma	13
Oral ferroportin inhibitor vamifeport for improving iron homeostasis and erythropoiesis in β-thalassemia: current evidence and future clinical development	13
Screening tools for hereditary hemolytic anemia: new concepts and strategies	12
Acute chest syndrome of sickle cell disease: genetics, risk factors, prognosis, and management	12
Renal disease associated with chronic myeloproliferative neoplasms	12
Copper deficiency, a rare but correctable cause of pancytopenia: a review of literature	11
Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: research priorities for mucocutaneous bleeding disorders	10
Targeting CD123 in BPDCN: an emerging field	10
Synovitis in hemophilia: preventing, detecting, and treating joint bleeds	10
Identification and management of fetal anemia due to hemolytic disease	10
Overcoming the challenges of treating hemophilia in resource-limited nations: a focus on medication access and adherence	10
Exercise and anemia in cancer patients: could it make the difference?	10
Therapeutic strategies, including allogeneic stem cell transplantation, to overcome relapsed/refractory adult T-cell acute lymphoblastic leukemia	10
Strategies to increase access to basic sickle cell disease care in low- and middle-income countries	9
Immunodeficiency-associated Hodgkin lymphoma	9
Chronic lymphocytic leukemia prognostic models in real life: still a long way off	9
Lived experience experts: a name created by us for us	9
The role of platelets, neutrophils and endothelium in COVID-19 infection	9
A comprehensive overview of daratumumab and carfilzomib and the recently approved daratumumab, carfilzomib and dexamethasone regimen in relapsed/refractory multiple myeloma	9
Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: facilitating research through infrastructure, workforce, resources and funding	9
Romiplostim in adults with newly diagnosed or persistent immune thrombocytopenia	9
Long-term hypercoagulability, endotheliopathy and inflammation following acute SARS-CoV-2 infection	9
CD123-targeted therapy in acute myeloid leukemia	8
Chronic neutropenia: how best to assess severity and approach management?	8
Applying World Health Organization 2020 guidelines on physical activity and sedentary behavior to people with hemophilia	8
Best practices and recommendations for drug regimens and plasma exchange for immune thrombotic thrombocytopenic purpura	8
Strategies to overcome the diagnostic challenges of autoimmune hemolytic anemias	8
New directions to develop therapies for people with hemophilia	8
A new decade: novel immunotherapies on the horizon for relapsed/refractory multiple myeloma	8
Post-COVID-19 hematologic complications: a systematic review	8
Association of tuberculosis in patients with chronic myeloid leukemia: a treatment proposal based on literature review	8
Recent guidelines for high-dose chemotherapy and autologous stem cell transplant for systemic AL amyloidosis: a practitioner’s perspective	8
Outcomes and long-term effects of hematopoietic stem cell transplant in sickle cell disease	7
An expert spotlight on inferior vena cava filters	7
A critical evaluation of crizanlizumab for the treatment of sickle cell disease	7
Endothelial dysfunction and vascular complications after allogeneic hematopoietic cell transplantation: an expert analysis	7
The National Hemophilia Foundation State of the Science Research Summit initiative: executive summary	7
Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: research priorities to transform the care of people with hemophilia	7
Fedratinib, the first selective JAK2 inhibitor approved for treatment of myelofibrosis – an option beyond ruxolitinib	7
The relationship between anemia and obesity	7
Cardiovascular involvement in patients affected by multiple myeloma: a comprehensive review of recent advances	7
Hemophilic arthropathy: a teaching approach devoted to hemophilia treaters in under-development countries	7
Consanguineous marriage and rare bleeding disorders	7
Efficacy and safety of thrombopoietin receptor agonists in the treatment of thrombocytopenia after hematopoietic stem cell transplantation: a meta-analysis and systematic review	7
Optimizing outcomes for haploidentical hematopoietic stem cell transplantation in severe aplastic anemia with intensive GVHD prophylaxis: a review of current findings	7

Acalabrutinib: a bruton tyrosine kinase inhibitor for the treatment of chronic lymphocytic leukemia	7
Palliative care for patients with hematologic malignancies: are we meeting patients’ needs early enough?	6
Thrombotic events in children and adolescent patients with SARS-CoV-2 infection: a systematic review with meta-analysis on incidence and management	6
A systematic literature review of the epidemiology, quality of life, and economic burden, including disease pathways and treatment patterns of relapsed/refractory classical Hodgkin lymphoma	6
Optimizing health-related quality of life in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors	6
The current role of artificial intelligence in hemophilia	6
G-CSF primary prophylaxis use and outcomes in patients receiving chemotherapy at intermediate risk for febrile neutropenia: a scoping review	6
Improving symptom burden and quality of life in patients with myelofibrosis: current strategies and future directions	6
Hematopoietic stem cell transplantation for classical inherited bone marrow failure syndromes: an update	6
Hemostatic therapy as a management strategy for acquired hemophilia: what does the future hold?	6
Tyrosine kinase inhibitor discontinuation in the management of chronic myeloid leukemia: a critical review of the current practice	6
Construction of a DLBCL Prognostic Signature Based on Tumor Microenvironment	6
Venetoclax for the treatment of elderly or chemotherapy-ineligible patients with acute myeloid leukemia: a step in the right direction or a game changer?	6
An evaluation of ferric derisomaltose as a treatment for anemia	6
Extended post-discharge thromboprophylaxis in hospitalized COVID-19 patients	6
The value of the red cell distribution width index versus other parameters in the differentiation between iron deficiency anemia and beta thalassemia trait among children in Mosul, Iraq	6
Chemokine receptor CXCR4: An important player affecting the molecular-targeted drugs commonly used in hematological malignancies	5
Total knee arthroplasty in hemophilia: lessons learned and projections of what’s next for hemophilic knee joint health	5
Selinexor for the treatment of patients with previously treated multiple myeloma	5
How low risk are low risk myelodysplastic syndromes?	5
Hematopoietic cell transplantation during COVID-19 pandemic: experience from a tertiary hospital in Madrid	5
Real-world comparison of direct-acting oral anticoagulants and vitamin K antagonists in chronic kidney disease: a systematic review and meta-analysis	5
Comparison of blinatumomab and CAR T-cell therapy in relapsed/refractory acute lymphoblastic leukemia: a systematic review and meta-analysis	5
Secondary erythrocytosis	5
Risk of vaso-occlusive episodes in patients with sickle cell disease exposed to systemic corticosteroids: a comprehensive review	5
Management of patients with antiphospholipid antibodies: what to do in laboratory scenarios that do not fit the guidelines	5
Pain management in people with hemophilia in childhood and young adulthood	5
Voxelotor for the treatment of sickle cell disease in pediatric patients	5
Bispecific antibodies in acute lymphoblastic leukemia therapy	5
Predictors of relapse and preventative strategies in immune thrombotic thrombocytopenic purpura	5
CD43 in the malignant flow cytometry laboratory in 2020	5
Immunomodulators in newly diagnosed multiple myeloma: current and future concepts	5
Patient characteristics and management practices in chronic myeloid leukemia in Turkey: reflections from an expert meeting	5
Utilizing the prognostic impact of minimal residual disease in treatment decisions for pediatric acute lymphoblastic leukemia	5
Redefining efficacy and safety endpoints for chronic lymphocytic leukemia in the era of targeted therapy	5
New developments in the diagnosis and characterization of Waldenström’s macroglobulinemia	5
Reducing infectious complications after allogeneic stem cell transplant	5
An update on the pathogenesis and diagnosis of thrombotic thrombocytopenic purpura	5
Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: research priorities for ultra-rare inherited bleeding disorders	5
An evaluation of deferiprone as twice-a-day tablets or in combination therapy for the treatment of transfusional iron overload in thalassemia syndromes	5
Keeping a balance in chronic lymphocytic leukemia (CLL) patients taking ibrutinib: ibrutinib-associated adverse events and their management based on drug interactions	5
The important role of intensive induction chemotherapy in the treatment of acute myeloid leukemia	4
Real-world study of rurioctocog alfa pegol and emicizumab in US clinical practice among patients with hemophilia A	4
D-Dimer: an analyte with increasing application in Covid-19 infection	4
The National Hemophilia Foundation’s State of the Science Research Summit: the foundation of a national research blueprint for inherited bleeding disorders	4
Emerging concepts for assessing and predicting treatment-free remission in chronic myeloid leukemia patients	4
Rational hemostatic management in cirrhosis: from old paradigms to new clinical challenges	4
Trend of fluctuations of antithrombin in plasma of patients with COVID-19: a meta-analysis and systematic review	4
Advances in therapeutic strategies for primary CNS B-cell lymphomas	4
Real-world outcomes for the treatment of relapsed/refractory multiple myeloma patients with lenalidomide-dexamethasone combinations in a Latin American country. A retrospective cohort study from gr	4
Advances in viral oncolytics for treatment of multiple myeloma – a focused review	4
Chronic myelomonocytic leukemia - a review	4
Patient-centered care in von Willebrand disease: are we there yet?	4
HIV-1 infection in sickle cell disease and sickle cell trait: role of iron and innate response	4
Smoldering multiple myeloma 40 years later: a story of unintended disease	4
Are myelodysplastic syndromes ready for venetoclax? Exploring future potential and considerations	4
Osteoporosis in hemophilia: what is its importance in clinical practice?	4
An update on novel therapies for treating patients with arterial thrombosis	4
Emerging data on thrombopoietin receptor agonists for management of chemotherapy-induced thrombocytopenia	4
Management of relapsed or refractory large B-cell lymphoma in patients ineligible for CAR-T cell therapy	4
Radiation therapy prior to CAR T-cell therapy in lymphoma: impact on patient outcomes	4
Risk of infection in adult patients with primary immune thrombocytopenia (ITP): a systematic review	4
Pregnancy and sickle cell disease: an overview of complications and suggested perinatal care	4
Etranacogene dezaparvovec for the treatment of adult patients with severe and moderately severe hemophilia B	4
Evaluating ropeginterferon alfa-2b for the treatment of adults with polycythemia vera	4
Monoclonal antibodies used for the management of hemataological disorders	4
Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: research to advance the health of people with inherited bleeding disorders with the pote	3
The efficiency of autologous stem cell transplantation as the first-line treatment for nodal peripheral T-cell lymphoma: results of a systematic review and meta-analysis	3
Emerging roles of microRNAs in acute lymphoblastic leukemia and their clinical prospects	3
An evaluation of asciminib for patients with chronic myeloid leukemia previously treated with ≥2 tyrosine kinase inhibitors	3
Secondary primary malignancies after treatment with chemo-immunotherapy in treatment-naïve patients with CLL: a systematic literature review	3
Cost-effectiveness analysis of azacitidine maintenance therapy in patients with acute myeloid leukemia	3
Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: research priorities in health services; diversity, equity, and inclusion; and implementa	3
Efanesoctocog alfa for the prevention and treatment of bleeding in patients with hemophilia A	3
PTPN22 gene polymorphism as a genetic risk factor for primary immune thrombocytopenia in Egyptian children	3
Current evidence on the use of direct oral anticoagulants in patients with myeloproliferative neoplasm: a systematic review	3
Revisiting the prognostic role of FLT3 mutations in acute myelogenous leukemia	3
A real-world evidence analysis of the impact of switching from factor VIII to emicizumab prophylaxis in patients with hemophilia A without inhibitors	3
Hematopoietic cell transplants in resource-poor countries: challenges and opportunities	3
Dysregulated MAPK signaling pathway in acute myeloid leukemia with RUNX1 mutations	3

A new decade awaits sticky platelet syndrome: where are we now, how do we manage and what are the complications?	3
Molecular targets for the treatment of AML in the forthcoming 5th World Health Organization Classification of Haematolymphoid Tumours	3
Revisiting the treatment of anemia in the setting of chronic kidney disease, hematologic malignancies, and cancer: perspectives with opinion and commentary	3
Practical tips for managing FLT3 mutated acute myeloid leukemia with midostaurin	3
Interleukin-37, vascular endothelial growth factor A, and transforming growth factor-β1: promising biomarkers in primary immune thrombocytopenia	3
Current status of drug repositioning in hematology	3
Zanubrutinib for the treatment of Waldenström Macroglobulinemia	3
BTK inhibitor selection for chronic lymphocytic leukemia: which drug for which patient?	3
The delicate balance of graft versus leukemia and graft versus host disease after allogeneic hematopoietic stem cell transplantation	3
Anticoagulant therapy for splanchnic vein thrombosis: recent updates for patients with liver cirrhosis	3
A narrative review of consolidation strategies for young and fit patients with newly-diagnosed primary central nervous system lymphoma	3
Belantamab mafodotin for the treatment of relapsed/refractory multiple myeloma in heavily pretreated patients: a US cost-effectiveness analysis	3
What is the future of telomere length testing in telomere biology disorders?	3
Managing women of childbearing age with chronic myeloid leukemia: safety and treatment considerations	3
Managing blood supplies during natural disasters, humanitarian emergencies, and pandemics: lessons learned from COVID-19	3
Sickle cell disease in gulf cooperation council countries: a systematic review	3
Management of chronic myeloid leukemia in myeloid blastic phase with novel therapies: a systematic literature review	3
Role of daratumumab in the frontline management of multiple myeloma: a narrative review	3
Allogeneic hematopoietic stem cell transplantation for acute lymphoblastic leukemia: current status and future directions mainly focusing on a Chinese perspective	3
BCMA-targeted therapies for multiple myeloma: strategies to maximize efficacy and minimize adverse events	3
Complement-directed therapy for cold agglutinin disease: sutimlimab	3
Managing patients with myelofibrosis and thrombocytopenia	3
Emicizumab: a novel drug in hemophilia A prophylaxis – a narrative review	2
How can we assess and measure prognosis for MALT lymphoma? A review of current findings and strategies	2
Gastrointestinal bleeding in von Willebrand patients: special diagnostic and management considerations	2
An evaluation of mitapivat for the treatment of hemolytic anemia in adults with pyruvate kinase deficiency	2
Exploiting gene mutations and biomarkers to guide treatment recommendations in mantle cell lymphoma	2
Do we need more guidance on thrombophilia testing? Challenges and special considerations	2
Looking to the future of gene therapy for hemophilia A and B	2
Evaluating ravulizumab for the treatment of children and adolescents with paroxysmal nocturnal hemoglobinuria	2
Pregnancy-associated aplastic anemia: a case-based review	2
Advances in myelodysplastic syndromes: promising novel agents and combination strategies	2
The diagnosis, natural history, and management of von Willebrand disease in women in the age of guidelines	2
CircPTK2 promotes cell viability, cell cycle process, and glycolysis and inhibits cell apoptosis in acute myeloid leukemia by regulating miR-582-3p/ALG3 axis	2
Molecular therapeutics of hemophilia A and B	2
Defining treatment success in chronic lymphocytic leukemia: exploring surrogate markers, comorbidities, and patient-centered endpoints	2
Phenotypic variation in sickle cell disease: the role of beta globin haplotype, alpha thalassemia, and fetal hemoglobin in HbSS	2
Hematological disorders in children with Down syndrome	2
Current clinical strategies and emergent treatment landscapes in leukemic transformation of Philadelphia-negative myeloproliferative neoplasms	2
Applications of artificial intelligence in clinical management, research, and health administration: imaging perspectives with a focus on hemophilia	2
Positron emission tomography/magnetic resonance imaging (PET/MRI) vs. gastroscopy: Can it improve detection of extranodal marginal zone lymphomas of the stomach following H. pylori treatment?	2
Testing strategies used in the diagnosis of rare inherited bleeding disorders	2
Fetal anemia in monochorionic twins: a review on diagnosis, management, and outcome	2
Management of acute chest syndrome in patients with sickle cell disease: a systematic review of randomized clinical trials	2
An evaluation of venetoclax in combination with azacitidine, decitabine, or low-dose cytarabine as therapy for acute myeloid leukemia	2
Dual target dilemma: navigating epcoritamab vs. glofitamab in relapsed refractory diffuse large B-cell lymphoma	2
The promise of novel treatments for severe chronic neutropenia	2
Paving the way to precision medicine in multiple myeloma	2
Use of immunoglobulin replacement therapy in patients with secondary antibody deficiency in daily practice: a European expert Q&A-based review	2
A systematic review of economic evaluations for the pharmaceutical treatment of chronic lymphocytic leukemia and acute myeloid leukemia	2
Olutasidenib: a novel mutant IDH1 inhibitor for the treatment of relapsed or refractory acute myeloid leukemia	2
Assessing eligibility for treatment in acute myeloid leukemia in 2023	2
Efficacy and safety evaluation of eptacog beta (coagulation factor VIIa [recombinant]-jncw) for the treatment of hemophilia A and B with inhibitors	2
Soliciting international perspectives on an American national research agenda for inherited bleeding disorders	2
Relationship between the ABO blood group and Rhesus factors with COVID-19 susceptibility	2
Hemophilic arthropathy: how to diagnose subclinical bleeding early and how to orthopedically treat a damaged joint	2
Polycythemia vera: aspects of its current diagnosis and initial treatment	2
Intra-articular injection of platelet-rich plasma in patients with hemophilia and painful knee joint cartilage degeneration	2
Recent advances in surgery and its perioperative treatment in people with hemophilia	2
Current therapies for chronic lymphocytic leukemia: risk and prophylaxis strategies for secondary/opportunistic infections	2
Nutritional status of patients with lymphoproliferative neoplasms before and after the first-line treatment	2
Factors associated with blood pressure variation in sickle cell disease patients: a systematic review and meta-analyses	2
An evaluation of pembrolizumab for classical Hodgkin lymphoma	2
Bone marrow morphological features and therapy in patients with Philadelphia-negative neoplasms	2
Point-of-care ultronography can help detect subclinical hemarthrosis in hemophilic patients undergoing regular optimal clotting factor prophylaxis to achieve zero bleeding	2
Addressing unmet needs in rare bleeding disorders: selected poster extracts of recent research in hemophilia A and von Willebrand disease presented at the 14th Annual Congress of the European Associat	2
Real-world treatment patterns and outcomes of triple-class treated patients with multiple myeloma in the United States	2
Electromagnetic radiation: a new charming actor in hematopoiesis?	2
Non-intensive acute myeloid leukemia therapies for older patients	2
Aggressive natural killer cell leukemia: diagnosis, treatment recommendations, and emerging therapies	2